<?xml version="1.0" encoding="UTF-8"?>
<ref id="B89-biomedicines-08-00060">
 <label>89.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Csatary</surname>
    <given-names>L.K.</given-names>
   </name>
   <name>
    <surname>Moss</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Beuth</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Töröcsik</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Szeberenyi</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Bakacs</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H)</article-title>
  <source>Anticancer Res.</source>
  <year>1999</year>
  <volume>19</volume>
  <fpage>635</fpage>
  <lpage>638</lpage>
  <pub-id pub-id-type="pmid">10216468</pub-id>
 </element-citation>
</ref>
